{
    "AALR3.SA": {
        "short_name": "ALLIAR      ON      NM",
        "long_name": "Centro de Imagem Diagn\u00f3sticos S.A.",
        "summary": "Centro de Imagem Diagn\u00c3\u00b3sticos S.A. provides diagnostic medicine services in Brazil. Its diagnostic imaging services include imaging diagnosis and chart-based diagnosis; nuclear medicine and cytology; pathological anatomy; and clinical tests. The company also engages in the provision of health consulting, advisory, courses and lectures, and the services related to health; management of chronic diseases; scientific and technologic research and development related to diagnostic medicine; preparation, issue, publication, and distribution of newspapers, books, magazines, periodicals, and other media for the dissemination of scientific knowledge; and grant and management of business franchises. Centro de Imagem Diagn\u00c3\u00b3sticos S.A. was founded in 1992 and is headquartered in S\u00c3\u00a3o Paulo, Brazil.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "SAO",
        "market": "br_market",
        "country": "Brazil",
        "state": "SP",
        "city": "S\u00c3\u00a3o Paulo",
        "zipcode": "04020-060",
        "website": "http://ri.alliar.com",
        "market_cap": 1270262784
    },
    "DASA3.SA": {
        "short_name": "DASA        ON",
        "long_name": "Diagn\u00f3sticos da Am\u00e9rica S.A.",
        "summary": "Diagn\u00c3\u00b3sticos da Am\u00c3\u00a9rica S.A. provides diagnostic test services in Latin America. It offers approximately 3,000 types of examinations of clinical analyses and diagnostic imaging services. The company also provides support services to approximately 5,000 laboratories under the Alvaro brand, as well as operates for the public sector under the Cient\u00c3\u00adficaLab brand. The company was formerly known as Laborat\u00c3\u00b3rio Cl\u00c3\u00adnico Delboni Auriemo S.A. and changed its name to Diagn\u00c3\u00b3sticos da Am\u00c3\u00a9rica S.A. in August 17, 2000. The company was founded in 1966 and is based in Barueri, Brazil. Diagn\u00c3\u00b3sticos da Am\u00c3\u00a9rica S.A. is a subsidiary of Cromossomo Participa\u00c3\u00a7\u00c3\u00b5es II S.A.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "SAO",
        "market": "br_market",
        "country": "Brazil",
        "state": "SP",
        "city": "Barueri",
        "zipcode": "06455-010",
        "website": "http://www.dasa3.com.br",
        "market_cap": 31535362048
    },
    "PARD3.SA": {
        "short_name": "IHPARDINI   ON      NM",
        "long_name": "Instituto Hermes Pardini S.A.",
        "summary": "Instituto Hermes Pardini S.A., together with its subsidiaries, provides medical, dental, laboratory research, clinical analysis, and supplementary diagnostic and therapeutic services in Brazil. It offers clinical analysis tests, diagnostic imaging, vaccines, check-ups, and other diagnostic services through 124 centers in the states of Minas Gerais, Goi\u00c3\u00a1s, S\u00c3\u00a3o Paulo, and Rio de Janeiro. The company also provides lab-to-lab services, such as specialized tests for other laboratories, as well as consulting, training, and support services for its customers. It operates primarily through eight brands, including Hermes Pardini, Progen\u00c3\u00a9tica, Diagn\u00c3\u00b3stika, Biocod, DLE, Labfar, Toxicologia Pardini, and Solu\u00c3\u00a7\u00c3\u00a3o. The company serves hospitals, clinics, laboratories, and other companies in the health care sector. Instituto Hermes Pardini S.A. was founded in 1959 and is headquartered in Belo Horizonte, Brazil.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Diagnostics & Research",
        "exchange": "SAO",
        "market": "br_market",
        "country": "Brazil",
        "state": "MG",
        "city": "Belo Horizonte",
        "zipcode": "30140-070",
        "website": "http://www3.hermespardini.com.br",
        "market_cap": 2753652224
    }
}